Tissue-Link ApS: Financial statements 2023
CVR: 40633979
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Tissue-Link ApS (CVR 40633979) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 16,551 and a net result of DKK 5,830 compared with DKK -183,865 the year before. Equity in the 2023 report amounted to DKK 237,240. The solvency ratio was 93.2%.
- Gross Profit
- DKK 16,551
- Profit/Loss
- DKK 5,830
- Equity
- DKK 237,240
- Total Assets
- DKK 254,471
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 17 t. | 6 t. | 237 t. | - |
| 2022 | - | -231 t. | -184 t. | 231 t. | - |
| 2021 | - | 367 t. | 326 t. | 415 t. | - |
| 2020 | - | -214 t. | -189 t. | 89 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Tissue-Link ApS has published its annual report for 2022. Gross profit came to DKK -230,803, and the net result was DKK -183,865.
About Tissue-Link ApS
Tissue-Link ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Peter Aadal Nielsen. The board consists of Charlotte Videbæk (chair), Niels Ole Mikkelsen and Peter Aadal Nielsen. The company's owners include Kurt Bækgaard Osther, AADALBIOTECH ApS and LGM WINTHER HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -818,426 and a net result of DKK -771,522 compared with DKK -319,133 the year before. Equity in the 2025 report amounted to DKK -853,415.